May 17, 2023 10:51 AM EDTUpdated 11:22 AM

Ex-FDA neuro chief Billy Dunn is taking a spin through the revolving door with biopharma — and that's a problem

It’s been less than three months since the FDA put out word that Billy Dunn had left the agency following a controversial run highlighted by …

Upgrade to Premium for unlimited access and Premium exclusives.

UPGRADE

Ex-FDA neu­ro chief Bil­ly Dunn is tak­ing a spin through the re­volv­ing door with bio­phar­ma — and that's a prob­lem